��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Identifying Drugs for the Treatment of Spinocerebellar Ataxia Type 2 (SCA2)

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 171

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Daniel R. Scoles, PhD, FAAN (University of Utah)	The institution of Dr. Scoles has received research support from NIH.
	No disclosure on file
Stefan M. Pulst, MD, FAAN (University of Utah)	Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for venrock. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leverna. Dr. Pulst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Leninthal LLC. The institution of Dr. Pulst has received research support from NINDS. Dr. Pulst has received intellectual property interests from a discovery or technology relating to health care.
Kevin E. Chapman, MD (Barrow Neurological Institute at Phoenix Children's Hospital)	No disclosure on file